We are live on
!
Find out more
TC
Trilogy Capital Portfolio holdings
AUM
$2.58B
1-Year Est. Return
22.97%
This Fund
S&P 500
This Quarter
Est. Return
+7.41%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
–
AUM
$2.06B
AUM Growth
+$150M
(+7.8%)
Cap. Flow
+$17.5M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
40.15%
Holding
380
New
47
Increased
139
Reduced
153
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$63.6M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$56.7M |
| 3 |
Vanguard Long-Term Bond ETF
BLV
|
+$29M |
| 4 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$27.5M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$27.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Quality ETF
SPHQ
|
+$55.6M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$43.6M |
| 3 |
THOR Low Volatility ETF
THLV
|
+$40.7M |
| 4 |
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
|
+$35.7M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.51% |
| 2 | Financials | 4.06% |
| 3 | Technology | 3.53% |
| 4 | Healthcare | 1.45% |
| 5 | Industrials | 1.19% |
Similar funds
PC
RFP
EV
MC
PI
CL
CTA
VWM
Trilogy Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Trilogy Capital held 380 positions worth $2.06B, up 7.8% from $1.91B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trilogy Capital's Q2 2025 filing shows 47 new, 139 increased, 153 reduced and 18 closed positions. Its largest new stake was Vanguard Long-Term Bond ETF: 424,610 shares worth $29.5M. The largest sale was Invesco S&P 500 Quality ETF, an estimated $55.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 89% a quarter earlier, followed by Financials and Technology.
- Trilogy Capital's largest Q2 2025 buy was Vanguard Long-Term Bond ETF: 424,610 shares worth $29.5M.
- Trilogy Capital added most to State Street Technology Select Sector SPDR ETF in Q2 2025, an estimated $63.6M increase.
- Trilogy Capital's biggest Q2 2025 reduction was Invesco S&P 500 Quality ETF, cutting an estimated $55.6M.
- Trilogy Capital fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2025, selling an estimated $10.3M.
- Trilogy Capital's ten largest holdings make up 40% of its $2.06B portfolio in Q2 2025.
- Trilogy Capital opened 47 new positions and closed 18 in Q2 2025.
- Trilogy Capital's portfolio value rose 7.8% quarter-over-quarter to $2.06B.
Based on Trilogy Capital's 13F filing for Q2 2025, filed 18 Jul 2025.